Cargando…

The Association Between Frailty and Parkinson’s Disease in the ReSPOnD Trial

BACKGROUND: Frailty and Parkinson’s disease (PD) are both highly prevalent in older people, but few studies have studied frailty in people with Parkinson’s. Identifying frailty in this population is vital, to target new interventions to those who would most benefit. METHODS: Data were collected as p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Natalie, Gaunt, Daisy M., Whone, Alan, Ben-Shlomo, Yoav, Henderson, Emily J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Canadian Geriatrics Society 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904322/ https://www.ncbi.nlm.nih.gov/pubmed/33680260 http://dx.doi.org/10.5770/cgj.24.437

Ejemplares similares

The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen
por: Henderson, Emily J, et al.
Publicado: (2013)

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
por: Henderson, Emily J., et al.
Publicado: (2016)

Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
por: Neumann, S., et al.
Publicado: (2021)

Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson’s Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson’s disease using a self-contained wearable device
por: Smith, Matthew D., et al.
Publicado: (2022)

SPON1 is an independent prognostic biomarker for ovarian cancer
por: Miyakawa, Ryoya, et al.
Publicado: (2023)

SponDT (Spondylodiscitis Diagnosis and Treatment): spondylodiscitis scoring system
por: Homagk, Lars, et al.
Publicado: (2019)

Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023)

Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors
por: Tang, Jiali, et al.
Publicado: (2023)

Multimorbidity and Frailty: Tackling Complexity in Parkinson’s Disease
por: Tenison, Emma, et al.
Publicado: (2020)

Needs of patients with parkinsonism and their caregivers: a protocol for the PRIME-UK cross-sectional study
por: Tenison, Emma, et al.
Publicado: (2022)

Spon's estimating costs guide to electrical works: unit rates and project costs
por: Spain, Bryan
Publicado: (2007)

F-Spondin/spon1b Expression Patterns in Developing and Adult Zebrafish
por: Akle, Veronica, et al.
Publicado: (2012)

Spondin-2 (SPON2), a More Prostate-Cancer-Specific Diagnostic Biomarker
por: Qian, Xiaolong, et al.
Publicado: (2012)

Patterns of spon1b:GFP expression during early zebrafish brain development
por: Agudelo-Dueñas, Nathalie, et al.
Publicado: (2020)

SPON2 Is Upregulated through Notch Signaling Pathway and Promotes Tumor Progression in Gastric Cancer
por: Kang, Hyeon-Gu, et al.
Publicado: (2020)

Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2
por: Jiang, Hao, et al.
Publicado: (2021)

SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults
por: Fernandez, Shane, et al.
Publicado: (2021)

Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL‐6 trans‐signalling
por: Huo, Yanmiao, et al.
Publicado: (2022)

Tumor-derived exosomal HOTAIRM1 regulates SPON2 in CAFs to promote progression of lung adenocarcinoma
por: Chen, Zhipeng, et al.
Publicado: (2022)

Ventral Striatal Dopamine Synthesis Capacity Predicts Financial Extravagance in Parkinson’s Disease
por: Lawrence, Andrew D., et al.
Publicado: (2013)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

Acceptability of an In-home Multimodal Sensor Platform for Parkinson Disease: Nonrandomized Qualitative Study
por: Morgan, Catherine, et al.
Publicado: (2022)

Observation of a spon 4 neutral meson with 2 GeV mass decaying in $\pi^{ordm} \pi^{ordm}$
por: Alper, B
Publicado: (1975)

SPON1 Can Reduce Amyloid Beta and Reverse Cognitive Impairment and Memory Dysfunction in Alzheimer’s Disease Mouse Model
por: Park, Soo Yong, et al.
Publicado: (2020)

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial
por: Stevens, Kara N., et al.
Publicado: (2022)

Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL)
por: Ypinga, Jan H. L., et al.
Publicado: (2021)

Transcriptional Activation of Matricellular Protein Spondin2 (SPON2) by BRG1 in Vascular Endothelial Cells Promotes Macrophage Chemotaxis
por: Li, Nan, et al.
Publicado: (2020)

FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
por: Li, Hailong, et al.
Publicado: (2023)

Antibacterial Effect and Therapy of Chronic Skin Defects Using the Composite Bioscaffold Polycaprolactone/GelitaSpon/Povidone-Iodine in Domestic Dogs
por: Šišková, Barbora, et al.
Publicado: (2023)

Results of the RENAISSANCE Study: REsponse to BNT162b2 COVID-19 vacciNe—short- And long-term Immune reSponSe evAluatioN in health Care workErs
por: Pani, Arianna, et al.
Publicado: (2021)

Parkinson’s Disease Subtypes in the Oxford Parkinson Disease Centre (OPDC) Discovery Cohort
por: Lawton, Michael, et al.
Publicado: (2015)

Primary care approach to frailty: Japan’s latest trial in responding to the emerging needs of an ageing population
por: Rosenberg, Megumi, et al.
Publicado: (2020)

Corrigendum: Transcriptional Activation of Matricellular Protein Spondin2 (SPON2) by BRG1 in Vascular Endothelial Cells Promotes Macrophage Chemotaxis
por: Li, Nan, et al.
Publicado: (2021)

The authors respond to: “Delayed discharge and frailty, delirium and functional decline”
por: Jerath, Angela, et al.
Publicado: (2021)

The Parkinson’s Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measures
por: Luz, Matthias, et al.
Publicado: (2020)

PIK3AP1 and SPON2 Genes Are Differentially Methylated in Patients With Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) Syndrome
por: Lovšin, Ema, et al.
Publicado: (2020)

Proactive and Integrated Management and Empowerment in Parkinson's Disease: Designing a New Model of Care
por: Tenison, Emma, et al.
Publicado: (2020)

Proactive and Integrated Management and Empowerment in Parkinson’s Disease protocol for a randomised controlled trial (PRIME-UK) to evaluate a new model of care
por: Lithander, Fiona E., et al.
Publicado: (2023)

Determinants of coping styles of people with Parkinson’s Disease
por: Prins, Eva M., et al.
Publicado: (2023)

Blood biomarkers with Parkinson's disease clusters and prognosis: The oxford discovery cohort
por: Lawton, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_188cm4g3chr4gfav88gh852vb7